IDELVION® Newly Approved 3500 IU Vial to Provide Convenience to Patients Using Larger Volumes

IDELVION® Newly Approved 3500 IU Vial to Provide Convenience to Patients Using Larger Volumes

May 31, 2018 – IDELVION 14-day dosing option for some patients, combined with the larger vial size, will improve convenience with fewer vials and less infusions – New vial option delivers on CSL Behring’s promise to enhance current treatments and provide